Matinas Biopharma Is Highly Undervalued
September 07, 2019 at 17:15 PM EDT
With cash concerns put to rest, a solid lead product MAT9001, and a unique lipid nano-crystal delivery technology, I believe Matinas Biopharma is highly undervalued.
